Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
09/04/2002 | CN1367787A Water soluble SDZ-RAD esters |
09/04/2002 | CN1367778A Novel carboxylic acid derivatives with 5,6 substitutedpyrimidine ring, their production and utilization thereof as endothelin receptor antagonists |
09/04/2002 | CN1367775A Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation |
09/04/2002 | CN1367699A Composition containing extracts of butyrospermum parkii and use as medicament or dietary supplement |
09/04/2002 | CN1367695A Phthalazine derivatives for treating inflammatory diseases |
09/04/2002 | CN1367693A Pharmaceutical compositions containing poly(ADP-ribose) glycohydrolase inhibitors and method of using the same |
09/04/2002 | CN1367687A Calcilytic compounds |
09/04/2002 | CN1367653A Combined use of triglycerides containing medium chain fatty acids and exogenous lipolytic enzymes as feed supplements |
09/04/2002 | CN1367169A Substituted 6,6-Hetero-dicycloderivative |
09/04/2002 | CN1367018A Compound preparation of staphylococcolysis enzyme and its preparation method and application |
09/04/2002 | CN1367016A Compound preparation for curing diarrhea |
09/04/2002 | CN1367013A Tongfuzhixie preparation |
09/04/2002 | CN1367009A Medicine for curing hepatitis B |
09/04/2002 | CN1366998A Lutai oral liquor |
09/04/2002 | CN1366993A Kidney-supplementing liver-boosting medicine |
09/04/2002 | CN1366984A Preparation method of pure Chinese medicine 'Weiaikexing' for curing carcinoma of stomach |
09/04/2002 | CN1366982A Chinese medicine Tongshuyin for curing cardiopathy, biliary disease and kidney disease |
09/04/2002 | CN1366981A Application of agave americana and its using method |
09/04/2002 | CN1366976A Nano tortoise plastron preparation medicine and preparation method |
09/04/2002 | CN1366974A Nano Guilingji preparation medicine and preparation method |
09/04/2002 | CN1366973A Nano Guishe preparation medicine and preparation method |
09/04/2002 | CN1366969A Nano Shenling health-care preparation medicine and preparation method |
09/04/2002 | CN1366968A Nano Binlang Sixiao preparation medicine and preparation method |
09/04/2002 | CN1366967A Nano Biwen preparation medicine and preparation method |
09/04/2002 | CN1366959A Nano Tiaojing Cuyun preparation medicine and preparation method |
09/04/2002 | CN1366957A Nano Bawei Shenqi preparation medicine and preparation method |
09/04/2002 | CN1366953A Nano midday tea preparation medicine and preparation method |
09/04/2002 | CN1366948A Nano Fufang Fufangteng preparation medicine and preparation method |
09/04/2002 | CN1366945A Nano gan accumulation preparation medicine and preparation method |
09/04/2002 | CN1366937A Nano quiet heart and supplement kidney preparation medicine and preparation method |
09/04/2002 | CN1366934A Nano Huichunruyi preparation medicine amd preparation method |
09/04/2002 | CN1366931A Nano deerhorn preparation medicine and preparation method |
09/04/2002 | CN1366930A Nano Pretty swertia preparation medicine and preparation method |
09/04/2002 | CN1366927A Nano Jiangding preparation medicine and preparation method |
09/04/2002 | CN1366925A Nano stomach-clearing coptis preparation medicine and preparation method |
09/04/2002 | CN1366923A Nano kindey-benefiting preparation medicine and preparation method |
09/04/2002 | CN1366919A Nano Jiebai preparation medicine and preparation method |
09/04/2002 | CN1366918A Nano navel-warming preparation medicine and preparation method |
09/04/2002 | CN1366917A Nano Neibu Yangrong preparation medicine and preparation method |
09/04/2002 | CN1366916A Nano plum blossom tongue preparation medicine and preparation method |
09/04/2002 | CN1366914A Nano Mieaoling preparation medicine and preparation method |
09/04/2002 | CN1366910A Nano bovine bezoar fire-clearing preparation medicine and preparation method thereof |
09/04/2002 | CN1366908A Nano Jianbu preparation medicine and preparation method thereof |
09/04/2002 | CN1366899A Nano dizziness-clearing preparation medicine and preparation method thereof |
09/04/2002 | CN1366897A Nano hemp seed preparation and preparation method thereof |
09/04/2002 | CN1366896A Nano hemp intestine-moistening preparation medicine and preparation method thereof |
09/04/2002 | CN1366895A Nano supplement both qi and blood preparation medicine and preparation method thereof |
09/04/2002 | CN1366891A Nano clear and quiet preparation medicine and preparation method thereof |
09/04/2002 | CN1366886A Liquor for curing hemorrhagic coliinfection |
09/04/2002 | CN1090190C Heterocycle-condensed morphinoid derivatives and its preparing method and use |
09/04/2002 | CN1090189C Pyrazolopyrimidines type compound |
09/04/2002 | CN1090031C Novel use of ACE-inhibitor for treatment of dyspeptic symptoms |
09/04/2002 | CN1090030C Complex cow's milk gamma globulin and making method thereof |
09/03/2002 | US6444702 Central nervous system disorders |
09/03/2002 | US6444691 1,3-disubstituted ureas as ACAT inhibitors, and method of preparing thereof |
09/03/2002 | US6444689 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
09/03/2002 | US6444686 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
09/03/2002 | US6444679 Neurological and gastrointestinal disorders; delta opioid ligands or opioid receptors |
09/03/2002 | US6444677 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
09/03/2002 | US6444639 Human chorionic gonadotrophin (hcg) used to treat or prevent tumors, multiple sclerosis, inflammation or angiogenesis-dependent diseases |
09/03/2002 | US6444477 Assay to determine whether or not a compound is capable of antagonising 5-ht.sub.2b receptor activity, which assay comprises determining whether or not said compound is capable of antagonising said activity in the human colon. |
09/03/2002 | US6444446 Calcium binding proteolipid compositions and methods |
09/03/2002 | US6444443 Gene |
09/03/2002 | CA2258960C A process for preparing naphthyridones and intermediates |
09/03/2002 | CA2237189C 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
09/03/2002 | CA2160764C Fish pancreatic disease virus |
09/03/2002 | CA2140626C Hydroxamic acid derivatives as metalloproteinase inhibitors |
09/01/2002 | CA2373578A1 .beta.3, agonists and uses thereof |
08/29/2002 | WO2002066646A2 Neurotransmission-associated proteins |
08/29/2002 | WO2002066635A1 Transgenic animal having drug metabolism enzyme gene and utilization thereof |
08/29/2002 | WO2002066621A1 Attenuated live vaccine |
08/29/2002 | WO2002066516A2 Antibodies that bind both bcma and taci |
08/29/2002 | WO2002066511A2 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders |
08/29/2002 | WO2002066494A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
08/29/2002 | WO2002066475A2 Tricyclic androgen receptor modulator compounds |
08/29/2002 | WO2002066461A1 Pyrazole compounds useful as protein kinase inhibitors |
08/29/2002 | WO2002066460A1 Chemical compounds |
08/29/2002 | WO2002066459A1 Indole derivatives and their use as gnrh antagonists |
08/29/2002 | WO2002066458A2 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry |
08/29/2002 | WO2002066450A2 Anthrone derivatives and their use as ink inhibitors |
08/29/2002 | WO2002066436A1 Process for preparing 2-(4-chlorobenzolamino) -3-[2(1h) -quinolinon-4-yl]proprionic acid |
08/29/2002 | WO2002066432A1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
08/29/2002 | WO2002066431A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
08/29/2002 | WO2002066430A1 Tryptase inhibitors |
08/29/2002 | WO2002066427A2 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
08/29/2002 | WO2002066422A1 Phenethanolamine derivatives for treatment of respiratory diseases |
08/29/2002 | WO2002066061A1 Active oxygen generator containing photosensitizer for ultrasonic therapy |
08/29/2002 | WO2002066040A2 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus |
08/29/2002 | WO2002066026A2 Tramadol-based medicament |
08/29/2002 | WO2002066022A1 Retinoid hepatitis therapy |
08/29/2002 | WO2002066002A2 Pharmaceutical formulation |
08/29/2002 | WO2002065978A2 Functional agent for decomposing nicotine and method of preparing the same |
08/29/2002 | WO2002043649A3 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof |
08/29/2002 | WO2002042273A3 Acid derivatives useful as serine protease inhibitors |
08/29/2002 | WO2002040466A3 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders |
08/29/2002 | WO2002028858A3 Hexahydropyrazino `1'2' : 1, 6!- pyrido `3, 4-b! indole-1, 4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
08/29/2002 | WO2002022621A3 INTERPHENYLENE 7-OXABICYCLIC[2.2.1]HEPTANE OXAZOLES AS PROSTAGLANDIN F2a ANTAGONISTS |
08/29/2002 | WO2002022620A3 Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin f2$g(a) antagonists |
08/29/2002 | WO2002018324A3 Immunoregulatory compounds, derivatives thereof and their use |
08/29/2002 | WO2002008256A3 Peptides as ns3-serine protease inhibitors of hepatitis c virus |